New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Brought to you by 
BSC sells neurovascular unit to Stryker for $1.5bn
Nov 2010
Executive Summary
Gaining a new therapeutic area outside of its core orthopedic implants, Stryker Corp. has bought Boston Scientific Corp.'s neurovascular division for $1.4bn in cash up front plus $100mm in milestones. The acquired unit is the leading player in the global neurovascular market, which is worth $900mm.
Deal Industry
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Earnout
- Payment Includes Cash
- Includes Contract
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
BSC sells neurovascular unit to Stryker for $1.5bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice